Cite
HARVARD Citation
Sahebjam, S. et al. (2021). Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study. Neuro-oncology. 23 (4), pp. 677-686. [Online].